Skip to main content
Erschienen in: Acta Diabetologica 2/2018

05.12.2017 | Original Article

Portrait of women with type 1 or type 2 diabetes of childbearing age attending diabetes clinics in Italy: the AMD-Annals initiative

verfasst von: Marina Scavini, Maria Chiara Rossi, Marco Scardapane, Antonio Nicolucci, Valeria Manicardi, Giuseppina Russo, Paolo Di Bartolo, Carlo B. Giorda, Nicoletta Musacchio, Antonio Ceriello, Stefano Genovese, Chiara Molinari, Nicoletta Dozio, AMD-Annals Study Group

Erschienen in: Acta Diabetologica | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Aim

To describe characteristics relevant in case of an unplanned pregnancy for T1D or T2D women of childbearing age.

Methods

We analyzed the 2011 AMD-Annals dataset, compiling information from 300 clinics (28,840 T1D patients and 532,651 T2D patients). A risk score of unfavorable conditions for pregnancy included HbA1c > 8.0%; BMI ≥ 35; systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg; microalbuminuria/proteinuria; use of statins, ACE inhibitors, ARB; use of diabetes drugs other than metformin/insulin.

Results

The proportion of T2D cases increased from 30.8% (95% CI 29.9–32.4) at age 18–30 years to 67.5% (66.6–68.5) at age 36–45 years. The proportion of women with HbA1c < 7.0% was 20.4% (20.0–20.8) in T1D and 43.4% (42.8–43.9) in T2D women. Furthermore, 47.6% (47.0–48.3) of T1D women and 34.5% (33.9–35.0) of T2D women had HbA1c ≥ 8.0%. The prevalence of obesity (BMI ≥ 30) was sevenfold higher among T2D than T1D women [49.9% (49.4–50.5) and 7.4% (7.2–7.5), respectively]. T2D women were more likely to have hypertension or microalbuminuria than T1D women. Almost half of the T2D women were taking drugs not approved during pregnancy. At least one unfavorable condition for starting a pregnancy was present in 51% of T1D women of childbearing age and in 66.7% of T2D women.

Conclusions

Women with either T1D or T2D of childbearing age in Italy were far from the ideal medical condition for conception. Our data strongly support the need for counseling all women with diabetes about pregnancy planning.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
9.
Zurück zum Zitat Sweet Baby (2017). Abstract 9th International Symposium on Diabetes, Hypertension, Metabolic Syndrome & Pregnancy, Barcelona (Spain), 8–12 March 2017 Sweet Baby (2017). Abstract 9th International Symposium on Diabetes, Hypertension, Metabolic Syndrome & Pregnancy, Barcelona (Spain), 8–12 March 2017
14.
Zurück zum Zitat Alberti KG, Eckel RH, Grundy SM et al (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120(16):1640–1645. https://doi.org/10.1161/CIRCULATIONAHA.109.192644 CrossRefPubMed Alberti KG, Eckel RH, Grundy SM et al (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120(16):1640–1645. https://​doi.​org/​10.​1161/​CIRCULATIONAHA.​109.​192644 CrossRefPubMed
17.
Zurück zum Zitat Confidential Enquiry into Maternal and Child Health (2005) Pregnancy in women with type 1 and type 2 diabetes in 2002–03, England Wales and Northern Ireland. CEMACH, London Confidential Enquiry into Maternal and Child Health (2005) Pregnancy in women with type 1 and type 2 diabetes in 2002–03, England Wales and Northern Ireland. CEMACH, London
27.
Zurück zum Zitat Lei Q, Niu J, Lv L et al (2016) Clustering of metabolic risk factors and adverse pregnancy outcomes: a prospective cohort study. Diabetes Metab Res Rev 32:835–842CrossRefPubMed Lei Q, Niu J, Lv L et al (2016) Clustering of metabolic risk factors and adverse pregnancy outcomes: a prospective cohort study. Diabetes Metab Res Rev 32:835–842CrossRefPubMed
28.
Zurück zum Zitat Metascreen Writing Committee, Bonadonna R, Cucinotta D, Fedele D, Riccardi G, Tiengo A (2006) The metabolic syndrome is a risk indicator of microvascular and macrovascular complications in diabetes: results from metascreen, a multicenter diabetes clinic-based survey. Diabetes Care 29:2701–2707CrossRef Metascreen Writing Committee, Bonadonna R, Cucinotta D, Fedele D, Riccardi G, Tiengo A (2006) The metabolic syndrome is a risk indicator of microvascular and macrovascular complications in diabetes: results from metascreen, a multicenter diabetes clinic-based survey. Diabetes Care 29:2701–2707CrossRef
30.
Zurück zum Zitat Napoli A, Colatrella A, Botta R et al (2005) Contraception in diabetic women: an Italian study. Diabetes Res Clin Pract 67(3):267–272CrossRefPubMed Napoli A, Colatrella A, Botta R et al (2005) Contraception in diabetic women: an Italian study. Diabetes Res Clin Pract 67(3):267–272CrossRefPubMed
Metadaten
Titel
Portrait of women with type 1 or type 2 diabetes of childbearing age attending diabetes clinics in Italy: the AMD-Annals initiative
verfasst von
Marina Scavini
Maria Chiara Rossi
Marco Scardapane
Antonio Nicolucci
Valeria Manicardi
Giuseppina Russo
Paolo Di Bartolo
Carlo B. Giorda
Nicoletta Musacchio
Antonio Ceriello
Stefano Genovese
Chiara Molinari
Nicoletta Dozio
AMD-Annals Study Group
Publikationsdatum
05.12.2017
Verlag
Springer Milan
Erschienen in
Acta Diabetologica / Ausgabe 2/2018
Print ISSN: 0940-5429
Elektronische ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-017-1076-9

Weitere Artikel der Ausgabe 2/2018

Acta Diabetologica 2/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.